Author

admin

Browsing

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations and increased deals involving biotech stocks listed on the NASDAQ.

After dropping to a low of 3,637.05 in October 2023, the index climbed to a nearly three year peak of 4,954.813 on September 19, 2024. While the index had pulled back to 4,530.69 as of August 5, 2025, further growth could be in store in the future.

According to a Towards Healthcare analyst report, the global biotech market is expected to grow at a compound annual growth rate of 12.5 percent from now to 2034, reaching a valuation of US$5.04 trillion.

Driving that growth will be favorable government policies, investment in the sector, increased demand for synthetic biology and a rise in chronic disorders such as cancer, heart disease and hypertension.

The top NASDAQ biotech stocks have seen sizeable share price increases over the past year. For those interested in investing in biotech companies, the best-performing small-cap biotech stocks are outlined below.

Data was gathered on August 5, 2025, using TradingView’s stock screener. Small-cap biotech stocks with market caps between US$50 million and US$500 million at that time were considered for this list.

1. Tiziana Life Sciences (NASDAQ:TLSA)

Year-to-date gain: 227.8 percent
Market cap: US$256.36 million
Share price: US$2.26

Tiziana Life Sciences is a clinical-stage biopharma which is developing therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its pipeline of candidates is built on its patent drug delivery technology that provides a possible alternative to intravenous delivery. Tiziana’s lead candidate is intranasal foralumab, a fully human anti-CD3 monoclonal antibody.

Tiziana Life Sciences shares hit US$1.69 on March 7 after the company filed its investigational new drug application to the US Food and Drug Administration (FDA) for a Phase 2 clinical trial in amyotrophic lateral sclerosis (ALS), which is supported by the ALS Association. However, by early April that value had fallen back to US$0.78 per share.

A series of positive news flow later in the spring helped to give Tiziana shares another boost. In April, John Hopkins University and the University of Massachusetts commenced dosing of the biotech company’s intranasal foralumab in Phase 2 trials for patients with non-active secondary progressive multiple sclerosis. On May 7, the company shared positive results from the use of its lead candidate in improving the quality of life for patients with that form of multiple sclerosis.

Tiziana is also studying the use of intranasal foralumab for treating moderate Alzheimer’s disease. On May 9, it announced that PET scans of a patient with moderate Alzheimer’s showed a significant reduction in microglia activation associated with neuroinflammation after three months of treatment.

Shares of Tiziana reached US$1.62 on May 13.

On July 21, the company announced an ‘unexpected discovery’ in its findings of an immunologic analysis of the patient with Alzheimer’s disease.

‘In an unexpected discovery, the analysis revealed an increase in phagocytosis markers in classical monocytes, suggesting that nasal foralumab may enhance their ability to clear amyloid plaques,’ the press release states. ‘This unexpected effect may open new avenues for treating Alzheimer’s Disease by targeting both inflammation and amyloid accumulation.’

Tiziana’s share price climbed through the remainder of the month, hitting a year-to-date high of US$2.50 on July 31.

2. Palvella Therapeutics (NASDAQ:PVLA)

Year-to-date gain: 224.98 percent
Market cap: US$416.08 million
Share price: US$37.64

Palvella Therapeutics is a clinical-stage biopharma developing treatments targeting rare genetic skin diseases for which there are no FDA-approved therapies. The company’s product pipeline centers on its patented QTORIN platform, which has an initial focus on rare genetic skin diseases.

Its lead product candidate, QTORIN rapamycin, is currently in a Phase 2 clinical trial in cutaneous venous malformations, and a Phase 3 clinical trial in microcystic lymphatic malformations (LM). QTORIN rapamycin has been granted breakthrough therapy designation, orphan drug designation and fast track designation from the FDA for the treatment of microcystic LMs.

After starting the year at US$12.00, shares of Palvella had surged to US$20.99 by February 18. About a week earlier, the company had shared plans to expand the Phase 3 trial to include pediatric patients from three to five years of age. That momentum in Palvella’s share price continued to rally to US$29 per share on March 13.

June produced a number of significant milestones for Palvella. On June 9, the company received initial proceedings from a grant issued by the FDA Office of Orphan Products Development for its Phase 3 trial, and on June 23, it completed enrollment for the trial with 51 subjects, 25 percent over its target. The company closed out the month with news it was added to the broad-market Russell 3000 Index and the Russell 2000 Index.

The company said it remains on track to deliver top-line Phase 3 data in Q1 2026 to support its planned new drug application submission later that year.

While the company didn’t release news in July, Palvella Therapeutics’ share price climbed significantly through the month to hit a year-to-date high of US$39.87 on July 28.

3. OKYO Pharma (NASDAQ:OKYO)

Year-to-date gain: 163.03 percent
Market cap: US$117.35 million
Share price: US$3.13

OKYO Pharma is a clinical-stage biopharma developing therapies for the treatment of neuropathic corneal pain and dry eye disease. Its lead candidate is urcosimod, a non-steroidal anti-inflammatory and non-opioid analgesic.

So far in 2025, the company has achieved multiple milestones related to its Phase 2 trial of urcosimod for treatment of neuropathic corneal pain.

On April 30, OKYO announced plans to end the trial early to analyze the data from the patients who had completed the trial, with the goal of accelerating its clinical development and expanding the program. Supporting the decision was the fact that urcosimod had previously demonstrated safety in OKYO’s completed Phase 2 trial of the candidate to treat patients with dry eye disease.

The next day, news broke that the FDA granted urcosimod fast track designation for the treatment of neuropathic corneal pain. OKYO’s stock price reached US$1.57 on May 1.

On July 17, OKYO posted strong top-line data from its Phase 2 clinical trial, and stated it is planning a meeting with the FDA to discuss next steps for its lead drug candidate. The following day, OKYO received US$1.9 million in non-dilutive funding to support its clinical development of urcosimod.

Shares of OKYO hit a year-to-date high of US$3.17 on August 5.

4. IO Biotech (NASDAQ:IOBT)

Year-to-date gain: 129.47 percent
Market cap: US$144.28 million
Share price: US$2.16

IO Biotech is a clinical-stage biopharmaceutical company developing immune-modulating therapeutic cancer vaccines based on its T-win technology platform, designed to activate T cells to target both tumor cells and the immune-suppressive cells. The company’s lead cancer vaccine candidate IO102-IO103, which has the brand name Cylembio, is currently in clinical trials.

The FDA granted breakthrough therapy designation to IO102-IO103 when used in combination with Merck’s (NYSE:MRK) anti-PD-1 therapy KEYTRUDA for the treatment of advanced melanoma based on positive Phase 1/2 first line metastatic melanoma data.

At the start of the year, IO Biotech completed enrollment in its Phase 2 trial of IO102-IO103 with KEYTRUDA as a treatment given before and after surgery for resectable melanoma or head and neck cancer.

On February 4, the company published results from a preclinical study of its second immune-modulatory therapeutic cancer vaccine candidate, IO112, targeting arginase 1, which plays a key role in immune suppression.

In mid-March, IO Biotech was named to Fast Company’s list of the World’s Most Innovative Companies of 2025. The following month, the company presented new preclinical data for its lead candidate IO102-IO103 as well as IO170, which targets Transforming Growth Factor beta.

In its Q1 2025 financial results and business highlights released on May 14, IO Biotech shared that a readout of primary endpoint data from its pivotal Phase 3 trial of its lead investigational therapeutic cancer vaccine in patients with advanced melanoma is expected in the third quarter of 2025.

Shares of IO Biotech reached a year-to-date high of US$2.40 on July 28.

5. Spero Therapeutics (NASDAQ:SPRO)

Year-to-date gain: 110.95 percent
Market cap: US$124.12 million
Share price: US$2.22

Spero Therapeutics is developing novel treatments for rare diseases and multi-drug resistant bacterial infections with high unmet need. The company’s lead drug candidate is tebipenem pivoxil hydrobromide (HBr), a late-stage development asset developed in collaboration with pharma giant GSK (NYSE:GSK) to treat complicated urinary tract infections (cUTIs), including pyelonephritis.

Spero has an exclusive license agreement with GSK for the development and commercialization of the drug candidate in all ex-Asia markets. The FDA has granted tebipenem HBr qualified infectious disease product and fast track designations.

Shares in Spero traded below US$1.00 for much of the first half of 2025. However, the stock’s value surged 245 percent on May 28 to reach US$2.35 per share after Spero reported that its Phase 3 trial evaluating tebipenem HBr for treating cUTIs met its primary endpoint and stopped early for efficacy. GSK plans to include the findings in a filing to the FDA during H2.

Spero shares reached a year-to-date high of US$3.04 on July 9.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keith Weiner, founder and CEO of Monetary Metals, discusses gold and silver’s performance so far this year and shares his outlook for the rest of 2025.

He also explains what makes today’s gold bull market different than those seen in prior years.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Lithium prices and mining stocks around the world soared this week after Chinese battery giant Contemporary Amperex Technology (CATL) (SZSE:300750,HKEX:3750) suspended operations at one of the world’s largest lithium mines.

The halt at the Jianxiawo lepidolite mine in Jiangxi province’s Yichun city, a hub for China’s lithium production, came after the mine’s permit expired on August 9.

CATL confirmed the closure on Monday (August 11), saying it is seeking a permit extension but offering no timeline for resuming output. The shutdown will last at least three months, according to people familiar with the matter cited by Bloomberg.

The mine produces around 65,000 tons of lithium carbonate equivalent (LCE) annually, equivalent to roughly 6 percent of global output, according to estimates.

That makes the stoppage one of the most significant supply interruptions in recent years for a metal central to electric vehicle (EV) batteries, grid storage, and consumer electronics.

The most-active lithium carbonate futures contract on the Guangzhou Futures Exchange (GFEX) jumped the daily limit of 8 percent on Monday (August 11), closing at 81,000 yuan (US$11,280) per ton for November delivery.

Meanwhile, spot prices in China also climbed, with Asian Metal reporting a 3 percent increase to 75,500 yuan per ton, the highest margin since February.

On the Liyang Zhonglianjin E-Commerce platform, November delivery prices surged over 10,000 yuan to around 85,500 yuan per ton.

Chandler Wu, senior analyst for battery raw materials at Fastmarkets, estimated that the shutdown would cut about 5,000 tons of LCE from China’s monthly output.

Market sentiment had been building for weeks amid speculation the mine’s license might not be renewed. By Wednesday, contracts on the GFEX were already posting sharp gains, with sellers in the spot market pushing up offers in line with futures prices.

Global mining stocks rally

The supply shock sent lithium miners’ shares higher from Sydney to New York.

In the US, Albemarle (NYSE:ALB) jumped more than 15 percent, Lithium Americas (NYSE:LAC) by 13 percent, and Chile’s SQM (NYSE:SQM) by 12 percent.

Australian producers saw similar gains: Pilbara Minerals (ASX:PLS,OTC Pink:PILBF) climbed up to 20 percent, Liontown Resources (ASX:LTR,OTC Pink:LINRF), surged 25 percent, and Mineral Resources (ASX:MIN,OTC Pink:MALRF) advanced 14 percent.

Analysts say the suspension may be linked to Beijing’s “anti-involution” campaign — an initiative aimed at curbing overcapacity and promoting more sustainable production across industries.

The policy theme has recently swept China’s financial markets and affected sectors from steelmaking to e-commerce and EVs.

China has been the world’s top processor of lithium for years. CATL, the world’s largest battery maker, has also aggressively invested in raw material supply chains to secure long-term access to critical minerals like lithium, nickel, and cobalt.

That vertical integration has helped China dominate the global EV market, but it has also contributed to oversupply concerns in the lithium sector.

CATL emphasized that the Jianxiawo shutdown would have “little impact” on its overall operations.

Even so, traders warn that the effects could be far-reaching if the suspension extends beyond Jianxiawo. Local authorities in Yichun have reportedly asked eight other miners to submit reserve reports by the end of September after audits revealed non-compliance in registration and approvals.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Here’s a quick recap of the crypto landscape for Wednesday (August 13) as of 9:00 a.m. UTC.

Get the latest insights on Bitcoin, Ethereum and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ethereum price update

Bitcoin (BTC) was priced at US$120,352, up by 1.5 percent over the last 24 hours. Its lowest valuation on Wednesday was $118,319, and its highest price was US$120,417.

Bitcoin price performance, August 13, 2025.

Chart via TradingView

Meanwhile, Ethereum continues to surge as it continues its weekend rally, up by over 9 percent at US$4,692.35. Its lowest valuation on Wednesday was US$4,265.81, and its highest was US$4,699.76.

Altcoin price update

  • Solana (SOL) was priced at US$201.23, up by 15.2 percent over 24 hours. Its lowest valuation for the day was US$174.20, and its highest price was US$201.58.
  • XRP was trading for US$3.29, up 5.2 percent in the past 24 hours and at its highest valuation of the day. Its lowest was US$3.12.
  • Sui (SUI) was trading at US$4.04, up by 11.7 percent over the past 24 hours. Its lowest valuation of the day was US$3.62 and its highest level was US$4.05.
  • Cardano (ADA) was trading at US$0.8755, up by 13.5 percent over 24 hours. Its lowest valuation on Wednesday was US$0.7682 and its highest was US$0.8828.

Today’s crypto news to know

World Liberty Financial sets up US$1.5B crypto treasury

World Liberty Financial, a digital asset venture backed by Donald Trump and his sons, has announced plans to establish a US$1.5 billion “crypto treasury” in partnership with Nasdaq-listed blockchain firm ALT5 Sigma.

Under the deal, ALT5 will sell US$1.5 billion worth of shares, half of which will be paid for in World Liberty Financial’s in-house token, $WLFI. The remaining funds will go toward purchasing $WLFI on the market, settling litigation, paying down debt, and other corporate uses.

The company says unnamed institutional investors and venture capital firms have participated in the share sale. Crypto treasury models have grown in popularity this year amid a friendlier US regulatory stance under Trump’s administration.

The project’s leadership is heavily tied to the Trump family, with Donald Trump listed as “co-founder emeritus” and Eric, Donald Jr., and Barron Trump holding co-founder titles.

As part of the arrangement, Eric Trump will join ALT5’s board and Zach Witkoff will serve as its chair.

Ethereum approaches all-time high on institutional buying surge

Ethereum (ETH) continues its weekend run, currently trading within the US$4,300–US$4,400 range and closing in on its November 2021 record high of US$4,878.

Analysts attribute the rally to strong technical momentum, reduced exchange supply, and a surge in institutional investment.

On August 8, ETH exchange-traded funds saw US$460 million in inflows, surpassing Bitcoin’s US$400 million on the same day. ETF and treasury-owned ETH holdings have risen from YS$24 billion in July to US$33 billion, driving available supply on exchanges to its lowest since 2016.

Investment firm BlackRock reportedly purchased over $12 billion worth of ETH on August 12, while Bitmine Immersion is seeking US$20 billion to acquire more, according to SEC filings.

While some analysts expect ETH to test its all-time high imminently, others caution that a pullback in September is likely.

Bullish raises US$1.1B in oversubscribed IPO

Crypto exchange operator Bullish has completed a US$1.1 billion initial public offering, pricing its 30 million shares at US$37 each and above the marketed range.

The higher pricing gives the firm a market capitalization of roughly US$5.4 billion, based on SEC filings. The IPO, which was more than 20 times oversubscribed, drew interest from major investors including BlackRock and ARK Investment, which together considered buying up to US$200 million in shares.

Bullish had previously abandoned a 2021 SPAC merger that would have valued it at US$9 billion, but has since positioned itself as an institutional-grade platform offering spot, margin, and derivatives trading.

The exchange’s largest shareholders after the offering will be co-founder and Block.one CEO Brendan Blumer with 30.1 percent, and board member Kokuei Yuan with 26.7 percent.

The IPO was led by JPMorgan, Jefferies, and Citigroup, with the company set to debut on the NYSE under the ticker BLSH.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Sranan Gold Corp. (CSE: SRAN) (FSE: P84) (Tradegate: P84) (‘Sranan’ or the ‘Company’) announces the commencement of its diamond drilling program for the Tapanahony Project in Suriname. Sranan’s drilling on the Randy trend is based on the positive drill results by Iamgold in 2012, small-scale mining by local community members, geologic and Lidar interpretation, and the results reported in recent news releases on high-grade grab samples from new shafts at Randy’s Pit (76.6 grams per tonne (gt) and 23.7 gt gold – see news release dated July 31, 2025) and trench channel samples of 5 metres of 36.7 gt gold (see news release dated August 7, 2025).

Sranan plans to validate the results of historical drilling by Iamgold since no core was preserved, and logs are missing structural and lithologic data. The Company is leveraging its team’s experience in the structural controls on mineralization gained from other gold projects in the Guiana Shield, and is using oriented core to better understand shear and vein orientation. Drill samples are being logged, photographed and cut using standard operating and QA/QC procedures. The first samples will be shipped soon as they are logged and sampled.

Figure 1: Recent drone image looking north showing hole 25RADD-001 in relation to channel 25RACH-001 and the shafts within the north end of Randy’s Pit.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/262263_srananimage.jpg

Dr. Dennis LaPoint, Executive VP of Exploration and Corporate Development, commented: ‘The drone image is an excellent figure to illustrate the potential of the Randy trend. The shafts with grab samples up to 6.5 g/t gold have been overlooked by Iamgold and the local miners, and the area of trench 25RACH-001 has not been prospected. We look forward to conducting systematic diamond drilling to test the strike and depth of the Randy trend.’

The Company will provide updates on results from the drilling program as they become available.

About Sranan Gold

Sranan Gold Corp. is engaged in the business of mineral exploration and the acquisition of mineral property assets in Suriname. The highly prospective Tapanahony Project is in the heart of Suriname’s modern-day gold rush. Tapanahony covers 29,000 hectares in one of the oldest and largest small-scale mining areas in Suriname.

Sranan Gold also owns the Aida Property consisting of five mineral claims covering an area of 2,335.42 hectares on the Shuswap Highland within the Kamloops Mining Division.

For more information, visit sranangold.com.

Qualified Person

Dr. Dennis J. LaPoint, Ph.D., P.Geo. a ‘qualified person’ as defined under National Instrument 43‐101, has reviewed and approved the scientific and technical information in this release. Dr. LaPoint is not independent of Sranan Gold, as he is the Company’s Executive VP of Exploration and Corporate Development.

Information contact
Oscar Louzada, CEO
+31 6 25438975

THE CANADIAN SECURITIES EXCHANGE HAS NOT APPROVED NOR DISAPPROVED THE CONTENT OF THIS PRESS RELEASE.

Forward-looking statements

Certain statements in this release constitute ‘forward-looking statements’ or ‘forward-looking information’ within the meaning of applicable securities laws including, without limitation, the timing, nature, scope and details regarding the Company’s exploration plans and results at its projects. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, its projects, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as ‘may’, ‘would’, ‘could’, ‘will’, ‘intend’, ‘expect’, ‘believe’, ‘plan’, ‘anticipate’, ‘estimate’, ‘scheduled’, ‘forecast’, ‘predict’ and other similar terminology, or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved. These statements reflect the company’s current expectations regarding future events, performance and results and speak only as of the date of this release. Further details about the risks applicable to the Company are contained in the Company’s public filings available on SEDAR+ (www.sedarplus.ca), under the Company’s profile.

Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262263

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Undrilled silver-rich and polymetallic occurrences are dispersed across a 55 km highly prospective east-west corridor

Silver47 Exploration Corp. (TSXV: AGA,OTC:AAGAF) (OTCQB: AAGAF) (‘Silver47’ or the ‘Company’) is pleased to provide a review of drill targeting across the highly-prospective Bonnifield District at the Red Mountain project near Fairbanks, Alaska (the ‘Red Mountain Project’).

Highlights:

  • Strong Alaskan High-Grade Resource Base: The Red Mountain Project already hosts an inferred mineral resource estimate of 15.6Mt at 336 g/t AgEq* totaling 168.6 million silver equivalent ounces comprised of two resource zones, Dry Creek and West Tundra Flats.
  • Leveraging Past Work: A database of historic geochemical and geophysical data, including 2,543 rock samples, 7,948 soil samples and 15,862 XRF soil samples has revealed a series of new targets outside the current resource zones that the Company is developing for drilling in 2026.
  • High Prospectivity and Unique Discovery Potential: Ongoing compilation highlights at least 35 mineralized prospects across the Red Mountain Project covering a 55 km trend many of which are undrilled or represent preliminary drilled discoveries open to expansion.
  • U.S. Silver and Critical Metal Focus: Multiple zones of high-grade surface mineralization marked by samples collected by a previous operator representing significant polymetallic upside are highlighted by grades of:
  • 1,295 g/t silver at the Galleon target
  • 3.8 g/t gold at the Horseshoe target
  • 16.2% copper at the Kiwi target
  • 32% zinc at the Anderson Mountain target
  • 20% lead at the Jack Frost target
  • 4,850 g/t antimony at the Bib target
  • 149 g/t gallium northeast of the West Tundra Flats Deposit
  • 98 g/t indium at the Jack Frost target
  • 0.13% tin at the Sheep Creek target
  • Drilling On-Going with Assays Pending: Nine holes have been completed at the Dry Creek and West Tundra Flats deposits where zones of massive, semi-massive and disseminated sulfides have been intersected in step-out and infill holes.

Galen McNamara, CEO, stated: ‘Our Red Mountain Project in Alaska is emerging as a premier silver and critical metals asset in the U.S. By leveraging extensive historic data, we’ve identified dozens of high-potential targets along broadly mineralized trends. The prospectivity of these targets was first identified by past operators, and I agree; the data suggest the likely presence of additional undiscovered and potentially giant VMS deposits on the project. I am unaware of any other domestic mineral projects with similar polymetallic discovery potential. In addition, ongoing drilling at Dry Creek and West Tundra Flats continues to intersect promising sulfide zones, with assays pending, positioning Red Mountain to deliver significant value and strengthen domestic critical mineral supply chains in the future.’

*Table 1: Combined Open Pit and Underground Inferred Mineral Resource Estimate for the Red Mountain Project, Alaska 

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10967/262306_8647920a74a5686f_002full.jpg

  1. The 2024 Red Mountain MRE was estimated and classified in accordance with the Canadian Institute of Mining, Metallurgy and Petroleum (‘CIM’) ‘Estimation of Mineral Resources and Mineral Reserves Best Practice Guidelines’ dated November 29, 2019, and the CIM ‘Definition Standards for Mineral Resources and Mineral Reserves’ dated May 10, 2014.
  2. Mr. Warren Black, M.Sc., P.Geo. of APEX Geoscience Ltd., a QP as defined by NI 43-101, is responsible for completing the 2024 Mineral Resource Estimate, effective January 12, 2024.
  3. Mineral resources that are not mineral reserves have not demonstrated economic viability. No mineral reserves have been calculated for Red Mountain. There is no guarantee that any part of the mineral resources discussed herein will be converted to a mineral reserve in the future.
  4. The estimate of mineral resources may be materially affected by environmental, permitting, legal, title, market, or other relevant factors.
  5. The quantity and grade of reported Inferred Resources is uncertain, and there has not been sufficient work to define the Inferred Mineral Resource as an Indicated or Measured Mineral Resource. It is reasonably expected that most of the Inferred Mineral Resources could be upgraded to Indicated Mineral Resources with continued exploration.
  6. All figures are rounded to reflect the relative accuracy of the estimates. Totals may not sum due to rounding. Reported grades are undiluted.
  7. A standard density of 2.94 g/cm³ is assumed for mineralized material and waste rock. Overburden density is set at 1.8 g/cm³. For mineralized material blocks with iron assays close enough to estimate an iron value for the block, density is calculated using the formula: density (g/cm³) = 0.0553 * Fe (%) + 2.5426.
  8. Metal prices are US$2,750/tonne Zn, US$2,100/tonne Pb, US$8,880/tonne Cu, US$1,850/oz Au, and US$23/oz Ag.

Figure 1. Plan Map of Red Mountain Project.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10967/262306_8647920a74a5686f_003full.jpg

Figure 2. Mineralized core from WT25-38 at the West Tundra Flat Deposit showing disseminated, semi-massive and massive sulfides consisting of pyrite, pyrrhotite, sphalerite, galena and chalcopyrite (172.65 to 180.5m downhole).

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10967/262306_8647920a74a5686f_004full.jpg

The Targets

Priority volcanogenic massive sulfide (VMS) exploration targets at the Red Mountain Project are dispersed across the highly prospective Bonnifield mining district. The targets vary from zinc-rich to copper-rich and many have associated high-grade silver and local gold mineralization.

Four main target trends are defined and include: Dry Creek Syncline, Keevy Trend, Last Chance Corridor and Wood River trend (Figure 1). Many of the targets across the Dry Creek Syncline area (Figure 1) were known historically, however, numerous high-priority targets across the Keevy and Last Chance areas were more recently identified through regional stream sediment, ridge-spur soil and rock geochemical surveys and project-wide EM geophysical surveys completed by a past project operator. Of the 30 known targets as well as other un-explored EM targets, only eleven targets have been drill tested, five of those with less than three holes each.

The Dry Creek Syncline: The best known targets associated with the Dry Creek Syncline are the Dry Creek and WTF deposits (combined inferred mineral resource of 15.6 million tonnes at 7% ZnEq or 335.7 g/t AgEq, totaling 168.6 million silver equivalent ounces*). Previous drilling at Dry Creek have returned high-grade intercepts, such as 22.3 m at 601 g/t AgEq (150.6 g/t Ag, 0.82 g/t Au, 5.86% Zn, 2.60% Pb, 0.13% Cu, DC24-105) from 18.9 m down hole.

VMS targets are located along both limbs of the project-scale, east-west trending Dry Creek syncline where approximately 40 km of prospective VMS stratigraphy (Mystic and Sheep Creek members of the Totatlanika schist) is well exposed (Figure 1). Many targets along the syncline are associated with pronounced EM anomalies and have been mostly defined by stream, soil and rock-chip geochemistry and limited ground geophysical surveys (magnetics and CSAMT). High priority targets across the Dry Creek Syncline area include:

  • Hunter Target: Massive sulfide mineralization at the Hunter target, 5.8 km west of Dry Creek, has been traced for over 500 m within a carbonaceous phyllite that is traced for over 1 km. Rock chip sampling of the discovery Hunter outcrop returned assays up to 616 g/t Ag, 18.6% Zn, 5.4% Pb, 2.5% Cu, and 0.33 g/t Au. Six drill holes in 2018, 2019 and 2021 successfully tested the dip-extent of the massive sulfide lens highlighted by 1.4m of 17.4% Zn, 3.9% Pb, 1.6% Cu, 90 g/t Ag and 0.23 g/t Au (HR18-01)2 and 1.8m of 13.8% Zn, 3.1% Pb, 56 g/t Ag, 0.2 g/t Au and 0.9% Cu (HR18-02)2. VMS-related mineralization at Hunter is therefore open in all directions and further drilling testing of the strike- and dip-extent is warranted.

  • Glacier Creek: The Glacier Creek suite of targets are approximately 12.3 km northwest of Dry Creek. The ~6 km long target area is primarily underlain by the highly-prospective Totatlanika schists and is defined by numerous EM anomalies and broad km-scale colour anomalies and associated sericite alteration. Rock-chip sampling is sparce and soil-surveys have only been ridge-spur, however, numerous multi-element geochemical anomalies have been defined together with barium enrichment in many samples. Seven holes were drilled across two programs covering a 2 km trend in 1998 and 2019. Additional geological mapping, soil and rock geochemical surveys are clearly warranted to advance the known targets and to define drill targets.

  • Galleon Target: The Galleon target is approximately 9.0 km north of Dry Creek. Similar to Glacier Creek, the Galleon target is primarily underlain by the Totatlanika schist where numerous showings of VMS-style, high-Pb-Zn-Cu massive sulfide mineralization have been discovered. Importantly, numerous samples from Galleon returned elevated to high-grade Ag and Au mineralization. Rock samples with up to 1,265 g/t Ag, 2.18 g/t Au, 2.4% Zn, 1.656% Pb and 1.7% Cu have been reported. Additional geological mapping, soil and rock geochemical surveys are clearly warranted to advance the known targets, followed by drill testing.

The Keevy Trend: The Keevy VMS trend consists of numerous high-grade VMS targets dispersed along 25 km of favorable Keevy Peak Formation and Healy Schist stratigraphy south of the Dry Creek Syncline area (Figure 1). From east to west the targets comprise Lowrider, Easy Ivan, Jack Frost, Yogi, Kiwi, and Yeti with multiple unexplored EM targets west of Yeti (Figure 1). These targets have massive sulfide occurrences comprised of sphalerite, galena and chalcopyrite with other key VMS indicators such as chert, black barite and broad zones of sericite alteration and strongly anomalous base-metal soil anomalies. Highlights and key indicators of VMS potential from the Keevy VMS trend include:

  • Kiwi: up to 316 g/t Ag, 16.2% Cu, 10.3% Zn, 1.7% Pb, and 2.8 g/t Au in rock samples

  • Easy Ivan: up to 87.1 g/t Ag, 6.0% Zn, 12.3% Pb, and 0.45% Cu in rock samples

  • Jack Frost: up to 285 g/t Ag, 14.0% Zn, 20.0% Pb, and 1.1% Cu in rock samples

  • Yeti: black barite with elevated silver and strong base metal soil anomalism

Besides sparce ridge-spur and local grid soil surveys, prospecting and rock sampling many of the targets are under-explored and represent priority targets for follow-up. Geological mapping and infill soil geochemical surveys are planned to advance many of the targets along the highly prospective Keevy Trend.

Last Chance Corridor: The Last Chance area of prospective VMS targets is centered approximately 40 km west of the Dry Creek deposit (Figure 1). These targets may represent the western extent of the Keevy Trend. Seven targets have been defined covering a prospective corridor of 15 km primarily underlain by the Healy Schist and include from east to west; Copper Creek, Grapple, Bib West, Bullseye, Ringer, Sheep Creek and Horseshoe. The VMS lenses exposed in outcrop consist of pyrrhotite, pyrite and/or sphalerite, galena and chalcopyrite. Only the Sheep Creek target has been drill tested (1979 program by US Borax1) and all targets are primarily defined based on rock, soil and stream sediment anomalism and airborne and local ground-based geophysical methods. Highlights from previous rock-chip sampling include:

  • Horseshoe: up to 8.3% Zn, 4.6% Pb, 0.76% Cu, 44 g/t Ag and 3.8 g/t Au in rock samples

  • Bib: up to 7.3% Zn, 5.1% Pb, 0.3% Cu, 60 g/t Ag and 0.47 g/t Au in rock samples

  • Grapple: up to 5.1% Zn, 13.2% Pb, 0.79% Cu and 139 g/t Ag in rock samples

  • Ringer: up to 0.72% Cu, 27 g/t Ag and 1.0 g/t Au in rocks samples

  • Sheep Creek: up to 306 g/t Ag, 4.3% Zn, 3.98% Pb, and 0.18% Cu in rock samples and 24.5 m of 1.3% Zn,1.0% Pb and 0.127% Sn in historical drilling1

Follow-up geological mapping, infill soil geochemical surveys and additional higher-resolution magnetic surveys are planned to further advance many of the Last Chance targets.

Wood River Trend: Four high-grade VMS targets cover a 24 km trend on the southern limb of a district-scale anticlinal fold that runs parallel to the Dry Creek syncline (Figure 1). The targets are hosted in prospective Healy and Wood River Assemblage schists which host VMS-related mineralization elsewhere in the Bonnifield district. From east to west the targets include West Fork, Cirque, Virginia Creek and Anderson Mountain. Select historical rock-chip sampling and select drilling highlights include:

  • West Fork: up to 3.5% Zn, 2.5% Pb, 1.2% Cu and 73g/t Ag in rock samples

  • Cirque: up to 487 g/t Ag, 13.2% Zn, 3.8% Pb, 12.4% Cu and 3.7 g/t Au in rock samples

  • Virginia Creek: historical drilling, 14.8m at 3.3% Zn, 0.8% Pb, 78 g/t Ag, 0.2g/t Au and 0.5% Cu1 and rock samples up to 2.8% Zn, 0.65% Pb, 74.1 g/t Ag, 1.01 g/t Au and 1.3% Cu

  • Anderson Mountain: historical drilling, 161 g/t Ag, 0.6 m at 22% Zn, 4.8% Pb and 0.6% Cu1 and up to 151 g/t Ag, 32% Zn, 8.8% Pb and 3.8% Cu in rock samples. The prospective VMS horizon is mapped for over 240 m

Follow-up geological mapping, infill soil geochemical surveys and additional higher-resolution magnetic surveys are warranted to further advance many of the Wood River trend of VMS targets.

Exploration Update

Drilling is ongoing at the Red Mountain Project where nine holes have been completed. Two holes have been completed at Dry Creek and seven holes at WTF. Zones of massive, semi-massive and disseminated sulfide mineralization have been intersected in both infill and step-out holes.

Data Verification

Historical data referenced herein, including but not limited to assay results, drill intercepts, and geological interpretations from previous exploration activities, have been sourced from publicly available records, archived reports, and third-party databases believed to be reliable. However, Silver47 has not independently verified this historical data through resampling, re-assaying, or other confirmatory methods due to the remote locations of the original samples or sites. As such, the Company cautions that this historical information may not conform to current NI 43-101 standards and should not be relied upon.

No new data verification procedures were undertaken specifically for this release beyond a review of available documentation. The Company plans to conduct future verification work, including drilling and sampling, to confirm and update these historical findings as part of ongoing exploration programs.

Qualified Person

The technical content of this news release has been reviewed and approved by Galen McNamara, P. Geo., the CEO of the Company and a qualified person as defined by National Instrument 43-101.

References

  1. Data reported by White Rock Minerals, WRM ASX announcement August 20th, 2018.

About Silver47 Exploration

Silver47 Exploration Corp. is a mineral exploration company, focused on uncovering and developing silver-rich deposits in North America. The Company is creating a leading high-grade US-focused silver developer with a combined resource totaling 236 Moz AgEq at 334 g/t AgEq inferred and 10 Moz at 333 g/t AgEq Indicated. With operations in Alaska, Nevada and New Mexico, Silver47 Exploration is anchored in America’s most prolific mining jurisdictions. For detailed information regarding the resource estimates, assumptions, and technical reports, please refer to the NI 43-101 Technical Report and other filings available on SEDAR at www.sedarplus.ca. The Company trades on the TSXV under the ticker symbol AGA and OTCQB under the ticker symbol AAGAF.

For more information about the Company, please visit www.silver47.ca and see the Technical Report filed on SEDAR+ (www.sedarplus.ca) and titled ‘Technical Report on the Red Mountain VMS Property Bonnifield Mining District, Alaska, USA with an effective date January 12, 2024, and prepared by APEX Geoscience Ltd.’

Follow us on social media for the latest updates:

    On Behalf of the Board of Directors,

    Mr. Galen McNamara
    CEO & Director

    For investor relations
    Giordy Belfiore
    604-288-8004
    gbelfiore@silver47.ca

    No securities regulatory authority has either approved or disapproved of the contents of this release. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

    FORWARD-LOOKING STATEMENTS

    This release contains certain ‘forward-looking statements’ and certain ‘forward-looking information’ as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as ‘may’, ‘will’, ‘expect’, ‘intend’, ‘estimate’, ‘upon’ ‘anticipate’, ‘believe’, ‘continue’, ‘plans’ or similar terminology. Forward-looking statements and information include, but are not limited to: the Company’s exploration and development activities and plans. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein, including but not limited to: the ability to close the Offering, including the time and sizing thereof, the insider participation in the Offering and receipt of required regulatory approvals; the use of proceeds not being as anticipated; the Company’s ability to implement its business strategies; risks associated with general economic conditions; adverse industry events; stakeholder engagement; marketing and transportation costs; loss of markets; volatility of commodity prices; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; industry and government regulation; changes in legislation, income tax and regulatory matters; competition; currency and interest rate fluctuations; and the additional risks identified in the Company’s financial statements and the accompanying management’s discussion and analysis and other public disclosures recently filed under its issuer profile on SEDAR+ and other reports and filings with the TSXV and applicable Canadian securities regulators. The forward-looking information are made based on management’s beliefs, estimates and opinions on the date that statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws.

    No forward-looking statement can be guaranteed, and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements.

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262306

    News Provided by Newsfile via QuoteMedia

    This post appeared first on investingnews.com

    Elon Musk on Monday threatened Apple with legal action over alleged antitrust violations related to rankings of the Grok AI chatbot app, which is owned by his artificial intelligence startup xAI.

    “Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation. xAI will take immediate legal action,” Musk wrote in a post on his social media platform X.

    Apple declined to comment on Musk’s threat.

    “Why do you refuse to put either X or Grok in your ‘Must Have’ section when X is the #1 news app in the world and Grok is #5 among all apps? Are you playing politics?” Musk said in another post.

    Apple last year partnered with OpenAI to integrate its ChatGPT chatbot into iPhone, iPad, Mac laptop and desktop products. Musk at the time said: “If Apple integrates OpenAI at the OS level, then Apple devices will be banned at my companies. That is an unacceptable security violation.”

    Prior to his legal threats against Apple, Musk had celebrated Grok surpassing Google as the fifth top free app on the App Store. When contacted by CNBC, xAI did not immediately respond to a request for further information on a potential lawsuit.

    CNBC confirmed that ChatGPT was ranked No. 1 in the top free apps section of the American iOS store, and was the only AI chatbot in Apple’s “Must-Have Apps” section. The App Store also featured a link to download OpenAI’s new flagship AI model, ChatGPT-5 at the top of its “Apps” section.

    OpenAI on Thursday announced GPT-5, its latest and most advanced large-scale AI model, following xAI’s release of its newest chatbot, Grok 4, last month.

    Musk has an ongoing feud with ChatGPT maker OpenAI, which he co-founded in 2015. The billionaire stepped down from its board in 2018, four years after saying that AI was “potentially more dangerous than nukes.”

    He is now suing the Microsoft-backed startup, and its CEO Sam Altman, alleging they abandoned OpenAI’s founding mission to develop artificial intelligence “for the benefit of humanity broadly.”

    Robert Keele, who headed the legal department at xAI, announced last week that he had left the company to spend more time with his family. In his announcement, Keele also acknowledged “daylight between our worldviews,” referring to Musk.

    In response to Musk’s antitrust threats against Apple, OpenAI CEO Sam Altman said in an X post: “This is a remarkable claim given what I have heard alleged that Elon does to manipulate X to benefit himself and his own companies and harm his competitors and people he doesn’t like.”

    This is not the first time Apple has been challenged on antitrust grounds. In a landmark case, the Department of Justice last year sued the company over charges of running an iPhone ecosystem monopoly.

    In June, a panel of judges also denied an emergency application from Apple to halt the changes to its App Store resulting from a ruling that the company could no longer charge a commission on payment links inside its apps, nor tell developers how the links should look.

    — CNBC’s Kif Leswing and Lora Kolodny contributed to this article.

    This post appeared first on NBC NEWS

    A Democratic whistleblower told the FBI that Adam Schiff approved leaking classified information in order to discredit President Donald Trump, according to newly-released documents.

    The documents, which were obtained by Just The News, were recently handed over to Congress by FBI Director Kash Patel. 

    The whistleblower reportedly worked for Democrats on the House Intelligence Committee for over ten years, and reported Schiff’s alleged behavior to the FBI in 2017.

    According to the report, the intelligence staffer called the leaking ‘treasonous’ and ‘illegal,’ in addition to being unethical. He was most recently interviewed by the FBI in 2023.

    The staffer also said that he personally attended a meeting where Schiff greenlit the leak.

    ‘When working in this capacity, [redacted staffer’s name] was called to an all-staff meeting by SCHIFF,’ the documents state, per Just The News. 

    ‘In this meeting, SCHIFF stated the group would leak classified information which was derogatory to President of the United States DONALD J. TRUMP. SCHIFF stated the information would be used to indict President TRUMP.’

    ‘[The whistleblower] stated this would be illegal and, upon hearing his concerns, unnamed members of the meeting reassured that they would not be caught leaking classified information,’ the report added.

    John Solomon, who co-authored the piece with Just The News’ Jerry Dunleavy, appeared on Fox News Channel’s ‘Hannity’ to discuss the report.

    ‘This is the first of several major leak investigations we’re going to see over the next several days,’ Solomon said. ‘You’re going to see other major people that were clearly identified by the FBI, having leaked classified secrets.’

    ‘Their own staff turned them in when interviewed by the FBI. Nothing, again, happened,’ he added. ‘It’s a common pattern. The question now is, in Donald Trump’s Justice Department, does that dynamic change?’

    Soon after the report was published, Patel shared it on X, saying that the FBI ‘found it [and] declassified it.’

    ‘Now Congress can see how classified info was leaked to shape political narratives – and decide if our institutions were weaponized against the American people,’ Patel’s post read.

    Fox News Digital’s Brooke Curto contributed to this report.

    This post appeared first on FOX NEWS

    President Donald Trump took aim at Ukrainian President Volodymyr Zelenskyy in a press event on Monday over his frustration with the Ukrainian leader’s objection to ‘land swapping.’

    ‘I get along with Zelenskyy, but, you know, I disagree with what he’s done, very, very severely, disagree. This is a war that should have never happened,’ Trump said, reiterating his belief that the Ukrainian president is in part at fault for Russia’s illegal 2022 invasion.

    ‘I was a little bothered by the fact that Zelensky was saying, ‘Well, I have to get constitutional approval’,’ Trump said. ‘I mean, he’s got approval to go into war and kill everybody, but he needs approval to do a land swap, because there’ll be some land swapping going on.’

    ‘I know that through Russia and through conversations with everybody,’ Trump added, noting it was ‘for the good of Ukraine.’

    Zelenskyy – who did not declare war on Russia, as Moscow had already invaded, did declare Martial Law on Feb. 24, 2022 with the approval of Ukraine’s parliament, which gave him presidential powers to mobilize a military response — made clear over the weekend that he objected to Trump’s ‘land swapping’ proposal and has repeatedly said it would require a national referendum under the nation’s constitution, not a unilateral decision by him. 

    Trump wouldn’t detail what exactly he hopes to get out of the meeting with Putin and described it as a ‘feel-out meeting,’ saying within ‘the first two minutes [he’ll] know exactly whether or not a deal can be made.’

    ‘I’m going in to speak to Vladimir Putin, and I’m going to be telling him, you got to end this war, you got to end it,’ Trump said, reiterating his belief that if he had won the 2020 election, Putin wouldn’t have invaded Ukraine, saying ‘he wasn’t going to mess with me.’

    ‘I go into that thing fully loaded right up there, and we’re going to see what happens,’ he continued. ‘It could be a good meeting, and we’ll go a step further. We’ll get it done. 

    ‘I’d like to see a ceasefire very, very quickly, very quick,’ he continued. ‘And, we’re going to be dealing with the European leaders and, we’re going to be dealing with President Zelensky and hopefully we’re going to have a great success.’

    This post appeared first on FOX NEWS

    President Donald Trump has renewed his call for Rep. Jasmine Crockett, D-Texas, to undergo a cognitive test. 

    ”Congresswoman’ Jasmine Crockett is a Low (Very!!!) I.Q. Individual, much in the mold of the AOC Plus Three Gang of Country Destroying Morons – Only slightly dumber,’ Trump wrote on TRUTH Social on Monday. 

    ‘Each of these political hacks should be forced to take a Cognitive Exam, much like the one I recently took while getting my ‘physical’ at our GREAT Washington, D.C., Military Hospital (WR!),’ Trump said. ‘As the doctors said, ‘President Trump ACED it, something that is rarely seen!’ These Radical Left Lunatics would all fail this test in a spectacular show of stupidity and incompetence. TAKE THE TEST!!!

    Trump previously said Rep. Alexandria Ocasio-Cortez, D-N.Y., should take a cognitive test in June when the progressive ‘Squad’ leader demanded his impeachment over the U.S. strikes on Iranian nuclear facilities. 

    Meanwhile, as the White House pushes Republican states to redistrict mid-cycle ahead of the 2026 midterm elections, Crockett has accused Trump of pushing a ‘white supremacy agenda’ and ‘diluting the voices of people of color.’ The Trump administration asserts that Democratic states have engaged in ‘gerrymandering’ for years and encouraged illegal immigration to boost their congressional influence. 

    In Texas, Democratic state lawmakers fled the state in an effort to stop the vote on a GOP redistricting plan that likely would have resulted in Republicans picking up five House seats. 

    Crockett has accused Trump of hurling the low IQ insult as a racially-coded tactic to insult ‘people of color,’ including ‘The Breakfast Club’ host Charlamagne tha God. 

    ‘Newsflash, Wannabe Dictator: I don’t care how many times you shake the Etch A Sketch trying to redraw these lines,’ Crockett wrote on X last week. ‘I’m not disappearing. I’ll be back, still on your behind every step of the way. We’ve already been over this. I’ve got the degrees, the credentials, and the receipts. If you’re looking for ‘low IQ,’ try looking in the mirror – or at your own Cabinet.’ 

    Despite the president describing her as having a low IQ, Crockett said Trump has the ‘most incompetent Cabinet in the history of this country,’ referring to the Signal-gate scandal earlier this year. 

    Crockett has also dubbed Trump a ‘Temu dictator.’ At a progressive rally in Phoenix, Arizona, earlier this month, the congresswoman said on stage, ‘Donald Trump is a piece of sh–.’ 

    ‘This is a person who has a problem with people of color. Period,’ she told CNN. ‘I don’t care how many Black MAGA [are] out there with [their] hats, I want to be clear, when we look at who it is that he’s kicking out of this country, it’s people of color.’ 

    This post appeared first on FOX NEWS